Key Financial Data Of Group

Astellas Pharma Inc. - Filing #7358593

Concept 2023-04-01 to
2023-12-31
As at
2023-12-31
2023-10-01 to
2023-12-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of group
Business results of group
Revenue
1,189,070,000,000 JPY
421,932,000,000 JPY
1,518,619,000,000 JPY
1,164,365,000,000 JPY
402,180,000,000 JPY
Profit (loss) before tax
73,630,000,000 JPY
132,361,000,000 JPY
180,238,000,000 JPY
Profit (loss), attributable to owners of parent
50,323,000,000 JPY
14,513,000,000 JPY
98,714,000,000 JPY
144,839,000,000 JPY
48,405,000,000 JPY
Comprehensive income, attributable to owners of parent
113,936,000,000 JPY
205,277,000,000 JPY
218,550,000,000 JPY
Equity attributable to owners of parent
1,503,255,000,000 JPY
1,507,954,000,000 JPY
1,570,424,000,000 JPY
Total assets
3,368,682,000,000 JPY
2,456,518,000,000 JPY
2,513,948,000,000 JPY
Basic earnings (loss) per share
28.06
8.09
54.24
79.43
26.56
Diluted earnings (loss) per share
27.96
54.09
79.40
Ratio of owners' equity to gross assets
0.446 xbrli:pure
0.614 xbrli:pure
0.625 xbrli:pure
Cash flows from (used in) operating activities
100,496,000,000 JPY
327,767,000,000 JPY
212,174,000,000 JPY
Cash flows from (used in) investing activities
-823,644,000,000 JPY
-84,500,000,000 JPY
-61,781,000,000 JPY
Cash flows from (used in) financing activities
583,131,000,000 JPY
-195,623,000,000 JPY
-91,120,000,000 JPY
Cash and cash equivalents
253,978,000,000 JPY
376,840,000,000 JPY
381,816,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.